Dear European Medicines Agency,
Under the right of access to documents in the EU treaties, as
developed in Regulation 1049/2001, I am requesting all
documentation relating to EMA decisions made, under Article
16 of the Staff Regulations, concerning Xavier Luria Oller who
worked for EMA. Specifically, I would like to receive a note of all Mr Luria Oller's job titles at EMA including dates held, copies of any
application(s) that Mr Luria Oller made under Article 16 of the Staff
Regulations to undertake a new professional activity (including
with Oryzon), and all correspondence or emails related
to the authorisation of the new role or roles.
Dear Ms Cann,
Thank you for your e-mail dated on 04 June 2012 in which you request access to documents held by the European Medicines Agency.
Provision of information in an open and transparent manner is part of the mission of the Agency.
We will deal with your request as soon as possible and in accordance with the principles and limits established in Regulation (EC) 1049/2001 regarding public access to European Parliament, Council and Commission documents as applicable to the EMA pursuant to article 73 of Regulation (EC) 726/2004.
This regulation sets out provisions which guarantee openness and transparency of the activities of European Institutions, whilst also ensuring the protection of certain public and private interests.
Under the above stated Regulation, you will receive a reply within 15 working days.
Document and Information Services
European Medicines Agency
7 Westferry Circus
[EMA request email]
Frequently Asked Questions (FAQs) have now been published on the Agency's website. It comprises answers to the most commonly asked questions submitted to the EMA. You are invited to consult it at the following Link http://www.ema.europa.eu/ema/index.jsp?c...
This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.